3 Stocks I Saw on T...
Health Care: Drugs
Celldex Therapeutics Inc. (CLDX: NASDAQ)
$4.08 0.09 | 2.26%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 11.90M | 21.29M | 57.00M | 44.26M |
| Receivables | 170.00K | 324.00K | 544.00K | 1.83M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 54.68M | 62.95M | 83.98M | 47.08M |
| Property, Plant & Equipment, Gross | 19.46M | 19.61M | 18.21M | 17.68M |
| Accumulated Depreciation & Depletion | 10.37M | 8.77M | 6.72M | 4.11M |
| Property, Plant & Equipment, Net | 9.09M | 10.83M | 11.49M | 13.57M |
| Intangibles | 24.92M | 26.84M | 29.98M | 2.47M |
| Other Non-Current Assets | 329.00K | 363.00K | 5.96M | 6.68M |
| Total Non-Current Assets | 43.31M | 47.00M | 56.39M | 22.72M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 97.99M | 109.94M | 140.36M | 69.79M |
| Accounts Payable | 935.00K | 931.00K | 1.44M | 2.15M |
| Short Term Debt | 6.14M | 13.52M | 2.16M | 49.95K |
| Other Current Liabilities | 219.00K | 818.00K | 0.00 | 3.01M |
| Total Current Liabilities | 14.30M | 20.21M | 14.41M | 14.10M |
| Long Term Debt | 9.01M | 8.89M | 11.68M | 825.54K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 5.97M | 5.59M | 40.51M | 36.73M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 14.97M | 14.48M | 52.19M | 37.56M |
| Total Liabilities | 29.27M | 34.69M | 66.60M | 51.66M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 68.72M | 75.26M | 73.77M | 18.13M |
| Common Par | 44.00K | 32.00K | 32.00K | 15.79K |
| Additional Paid In Capital | 271.03M | 232.68M | 228.86M | 136.66M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -205.01M | -160.21M | -157.67M | -121.15M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 2.65M | 2.75M | 2.55M | 2.61M |
| Total Capitalization | 77.73M | 84.14M | 85.45M | 18.96M |
| Total Equity | 68.72M | 75.26M | 73.77M | 18.13M |
| Total Liabilities & Stock Equity | 97.99M | 109.94M | 140.36M | 69.79M |
| Total Common Shares Outstanding | 44.21M | 32.06M | 31.69M | 15.79M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 39.50M | 31.87M | 19.82M | 14.22M |
| Diluted Weighted Shares Outstanding | 39.50M | 31.87M | 19.82M | 14.22M |
| Number of Employees | 103 | 94 | 90 | 78 |
| Number of Part-Time Employees | 0 | 6 | 3 | 3 |
Portfolios with CLDX
- Portfolio NameUser Type
- Userbio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Cheap Biotech Stocks Tha...
- User3rdwavemedia Portfolio 1
- UserSUPRATRADE 7 Top Stocks for...
- UserASCO 2010
- UserSolstock
Latest CLDX Headlines from TheStreet
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Celldex Targeted Drug Shrinks Breast Cancer 05.23.12 | 04:05 pm
- The Next Big Thing In Biotech: Celldex
05.18.12 | 07:05 am - 7 Stocks Under $10 Making Big Moves 05.17.12 | 12:05 pm
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Celldex Screw-Up Nixes ASCO Data Slot 05.01.12 | 07:05 am
- Biotech Stock Mailbag: All You Need to Know About Hep C Drugs 04.13.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- Biotech Stock Chat: Recap 03.15.12 | 11:03 am
Press Releases for CLDX
- Celldex Therapeutics To Present At The Jefferies 2012 Global Healthcare Conference - Business Wire 05.31.12 | 09:05 am
- Celldex’s CDX-011 Demonstrates High Response Rates In Patients With Metastatic Breast Cancer Expressing Elevated Levels Of GPNMB And In Triple Negative Disease - Business Wire 05.23.12 | 04:05 pm
- Celldex Therapeutics To Host Call To Announce Topline Results From The EMERGE Study In Advanced Breast Cancer - Business Wire 05.18.12 | 10:05 am
- Celldex Reports First Quarter 2012 Financial Results - Business Wire 05.03.12 | 08:05 am
- Celldex Announces Plans To Release Topline Results From The EMERGE Study In Advanced Breast Cancer - Business Wire 05.01.12 | 07:05 am
- Celldex Announces Exercise Of Over-Allotment Option - Business Wire 03.14.12 | 05:03 pm
- Celldex Reports Fourth Quarter And Fiscal 2011 Financial Results - Business Wire 03.07.12 | 07:03 am
- Celldex Therapeutics To Host Corporate 2011 Year-End And 2012 Objectives Update Call - Business Wire 02.29.12 | 03:02 pm
- Celldex Therapeutics To Present At The Citi 2012 Global Health Care Conference - Business Wire 02.24.12 | 10:02 am
- Celldex Prices Public Offering Of Common Stock - Business Wire 02.24.12 | 09:02 am
Partner Headlines for CLDX
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VOD - NASDAQ 05.24.12 | 12:05 pm
- Analyst Insights: Celldex, InterMune, American Tower, Thermo Fisher, Jiayuan.com May 24th - Wall St. Cheat Sheet 05.24.12 | 11:05 am
- After Hours Most Active for May 23, 2012 : NTAP, HPQ, BAC, BLK, IFSIA, QQQ, F, CLDX, KMI, PFE, ERIC, FB - NASDAQ 05.23.12 | 08:05 pm
- Breast Cancer Immunotherapy: A New Hope In The Fight - Seeking Alpha 03.09.12 | 08:03 am
- Notable Put Options Activity in Celldex Therapeutics - Benzinga 03.06.12 | 01:03 pm
- Notable Put Options Activity in Celldex Therapeutics - Benzinga 02.27.12 | 01:02 pm
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
